What Researchers Did
The researchers looked back at the records of five kidney failure patients with biopsy-proven calciphylaxis who were treated with hyperbaric oxygen (HBO2) therapy between March 1997 and February 2000.
What They Found
In this retrospective case series of five patients with calciphylaxis and end-stage kidney disease treated with HBO2, two patients had complete resolution of extensive necrotic skin ulcers and three did not. Three patients were on continuous ambulatory peritoneal dialysis and two were on chronic haemodialysis. Each patient received 25 to 35 treatments at 2.5 atmospheres for 90 minutes per treatment. The two patients whose ulcers healed had no adverse effects from HBO2 and showed improved oxygen pressure in the wound area when breathing 100% oxygen, measured at both normal and hyperbaric pressures. In the three patients whose lesions did not resolve, oxygen pressure was measured in two, and neither improved with 100% oxygen at normal pressure.
What This Means for Canadian Patients
For people with calciphylaxis, this small report describes healing in two of five patients given HBO2. The authors state that the data support a role for HBO2 in some patients, particularly those without uncontrolled secondary hyperparathyroidism, where they note there are few other treatment options. Anyone with this condition should talk with their kidney care team about whether HBO2 fits their situation.
Canadian Relevance
The study has a Canadian connection, as it was conducted by Canadian authors.
Study Limitations
This was a retrospective review of only five patients with no comparison group, so it cannot show that HBO2 caused the healing seen in two patients.